Screening for Osteoporosis

Elaine W Yu, MD. SScreening for Osteoporosis. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com (Accessed on February 24, 2020.).

Osteoporosis is a common disease that is characterized by low bone mass, microarchitectural disruption, and skeletal fragility, resulting in an increased risk of fracture. The goal of screening is to identify persons at increased risk of sustaining a low-trauma fracture who would benefit from intervention to minimize that risk.

Approaches to bone mineral density (BMD) screening vary from country to country, in part due to cost and questions regarding the efficacy of a broad population screening policy. The issues surrounding screening for osteoporosis in postmenopausal women and men are reviewed here. Controversies surrounding screening for osteoporosis in premenopausal women are reviewed separately. (See “Evaluation and treatment of premenopausal osteoporosis”, section on ‘Screening’.)

Detailed information about diagnosis, prevention, and treatment of osteoporosis is found elsewhere. (See “Clinical manifestations, diagnosis, and evaluation of osteoporosis in postmenopausal women” and “Clinical manifestations, diagnosis, and evaluation of osteoporosis in men” and “Prevention of osteoporosis” and “Overview of the management of osteoporosis in postmenopausal women” and “Treatment of osteoporosis in men”.)

Disponível Em: <https://www.uptodate.com/>